Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Premium Services
Financial News
Latest
Earnings
Guidance
Dividends
M&A
Buybacks
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Small-Cap
Markets
Pre-Market
After Hours
Movers
ETFs
Options
Cryptocurrency
Commodities
Bonds
Futures
Mining
Real Estate
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Investing Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
Analyst Ratings
Analyst Color
Latest Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Unusual Options Activity Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Compare Best Stocks

Best Momentum Stocks

Best Quality Stocks

Best Value Stocks

Best Growth Stocks

Comments

Loading...

Evolus Stock News

EOLSNASDAQ

Logo brought to you by Benzinga Data

Trade with Public

Trade with Public

$7.22

0.081.12%

At close: Dec 16, 4:00 PM EST

$7.22

-0.0005-0.01%

After Hours: 4:23 PM EST

News

Earnings Options Guidance Analyst Ratings Insider Trades Short Interest Stock Report

Latest Evolus Stock News | NASDAQ:EOLS | Benzinga

Get the latest news on Evolus stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Evolus performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Tuesday, December 02, 2025

Mizuho Maintains Outperform on Evolus, Lowers...
Benzinga Newsdesk

Thursday, November 06, 2025

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Evolus shares are trading higher after the co...
Benzinga Newsdesk

Wednesday, November 05, 2025

CORRECTION: Evolus Q3 Adj. EPS $(0.11) Beats ...
Benzinga Newsdesk
Evolus shares are trading higher after the co...
Benzinga Newsdesk
Evolus shares are trading higher after the co...
Benzinga Newsdesk
Evolus Affirms FY2025 Sales Guidance of $295....
Benzinga Newsdesk
Evolus Q3 EPS $(0.24) Beats $(0.26) Estimate,...
Benzinga Newsdesk
Earnings Scheduled For November 5, 2025
Benzinga Insights

Tuesday, November 04, 2025

Watching Evolus; Hearing Zacks Under $10 News...
Benzinga Newsdesk

Monday, September 08, 2025

BTIG Reiterates Buy on Evolus, Maintains $18 ...
Benzinga Newsdesk
Evolus Appoints Tatjana Mitchell As CFO, Effe...
Benzinga Newsdesk

Monday, August 25, 2025

Evolus Announces US Study Of Evolysse Sculpt ...
Benzinga Newsdesk

Wednesday, August 20, 2025

Evolus Submits Final FDA PMA Module For Evoly...
Benzinga Newsdesk

Wednesday, August 06, 2025

BTIG Maintains Buy on Evolus, Lowers Price Ta...
Benzinga Newsdesk
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Needham Downgrades Evolus to Hold, Maintains ...
Benzinga Newsdesk
Super Micro Computer Posts Downbeat Q4 Results, Joins Personalis, Snap And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Avi Kapoor
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
HC Wainwright & Co. Maintains Buy on Evolus, ...
Benzinga Newsdesk
Evolus shares are trading lower after the com...
Benzinga Newsdesk
Why Astera Labs Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket
Avi Kapoor

Tuesday, August 05, 2025

12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Evolus shares are trading lower after the com...
Benzinga Newsdesk
Evolus Lowers FY2025 Sales Guidance from $345...
Benzinga Newsdesk
Evolus Q2 Adj. EPS $(0.23) Misses $(0.10) Est...
Benzinga Newsdesk
Earnings Scheduled For August 5, 2025
Benzinga Insights

Monday, August 04, 2025

A Look Ahead: Evolus's Earnings Forecast
Benzinga Insights

Thursday, July 31, 2025

Evolus Announces Study In "JAMA Dermatology",...
Benzinga Newsdesk

Wednesday, July 09, 2025

Evolus Partners With Symatese To Commence Dis...
Benzinga Newsdesk

Tuesday, May 27, 2025

Evolus CFO Sandra Beaver Resigned; Company In...
Benzinga Newsdesk

Thursday, May 22, 2025

Evolus Publishes US Pivotal Study Results For...
Benzinga Newsdesk

Thursday, May 08, 2025

What Analysts Are Saying About Evolus Stock
Benzinga Insights
Needham Reiterates Buy on Evolus, Maintains $...
Benzinga Newsdesk

Wednesday, May 07, 2025

Evolus Affirms FY2025 Sales Guidance of $345....
Benzinga Newsdesk
Evolus Q1 Sales $68.50M Miss $72.20M Estimate
Benzinga Newsdesk
Evolus Shares Are Trading Lower After The Com...
Benzinga Newsdesk
Earnings Scheduled For May 7, 2025
Benzinga Insights

Monday, May 05, 2025

Evolus Replaces Existing $125M Credit Agreeme...
Benzinga Newsdesk

Thursday, April 17, 2025

This Twin Disc Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Avi Kapoor
BTIG Initiates Coverage On Evolus with Buy Ra...
Benzinga Newsdesk

Thursday, April 10, 2025

HC Wainwright & Co. Reiterates Buy on Evolus,...
Benzinga Newsdesk

Wednesday, April 09, 2025

Breaking Down Evolus: 8 Analysts Share Their Views
Benzinga Insights
Needham Reiterates Buy on Evolus, Maintains $...
Benzinga Newsdesk

Wednesday, March 05, 2025

Barclays Maintains Overweight on Evolus, Rais...
Benzinga Newsdesk
Assessing Evolus: Insights From 6 Financial Analysts
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Evolus,...
Benzinga Newsdesk
Needham Reiterates Buy on Evolus, Maintains $...
Benzinga Newsdesk

Tuesday, March 04, 2025

Evolus Sees FY25 Revenue $345M-$355M Vs $351....
Benzinga Newsdesk
Evolus Q4 2024 GAAP EPS $(0.11) Misses $(0.06...
Benzinga Newsdesk

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Zevra Therapeutics Inc

GH Research PLC

Bioage Labs Inc

Neumora Therapeutics Inc

Aardvark Therapeutics Inc

Aquestive Therapeutics Inc

SIGA Technologies Inc

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved